Linezolid Market to see Rapid Growth by 2028

The global Linezolid market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Linezolid is an antibiotic drug that is used for the treatment of serious bacterial infections such as gram-positive bacteria, pneumonia, skin infections, and infections that are resistant to other antibiotics by stopping the growth of bacteria. This drug is either consumed by mouth or by injecting directly into the vein. The major factor for the growth of the market is the increasing prevalence of pneumonia.

According to the World Health Organization (WHO), in 2019, pneumonia accounted for 14% of all children mortality with a mortality rate of 740,180 children under the age of five. Additionally, as per UNICEF 2021, the mortality rate due to pneumonia is more than 800,000 children under five every year or around 2,200 every day which includes over 153,000 newborns. Further, there are more than 1,400 cases of pneumonia per 100,000 children or 1 case per 71 children every year globally. Hence, the rising prevalence of pneumonia is increasing the risk for bacterial infections creating demand for linezolid.

To Request a Sample of our Report on Global Linezolid Market:  https://www.omrglobal.com/request-sample/linezolid-market

Some major players in the market include Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Alembic Pharmaceuticals Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2017, HQ SPCLT PHARMA announced that their Linezolid intravenous solution 200MG/100ML (2MG/ML), 600MG/300ML (2MG/ML) was approved by the FDA.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027

Segment Covered- 

  • By Type
  • By Application

Regions Covered-

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape– Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Alembic Pharmaceuticals Inc., among others.

A full Report of Global Linezolid Market is Available @  https://www.omrglobal.com/industry-reports/linezolid-market

Global Linezolid Market Report by Segment

By Type 

  • Injection
  • Tablets

By Application 

  • Hospital Acquired Pneumonia (HAP)
  • Community Acquired Pneumonia (CAP)
  • Complex Skin Or Skin Soft Tissue Infection (SSTI)
  • Vancomycin-Resistant Enterococcus (VRE) Infection
  • Others

Global Linezolid Market Report by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe

Asia-Pacific

  • India
  • China
  • Japan
  • South Korea
  • Rest of APAC

Rest of the World

  • Latin America
  • Middle East & Africa

Reasons to buy from us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/linezolid-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404